Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study

ConditionAcromegaly
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorIstituto Auxologico Italiano

About this trial

Acromegaly is a rare chronic disease due to excessive secretion of growth hormone (GH) and insulin-like growth factor-I (IGF-I), caused in over 98% of cases by GH-secreting pituitary adenoma. Prolonged exposure to GH/IGF-I excess is the cause of increased mortality and morbidity in these patients. Arthropathy occurs in about 75% of acromegalic patients. Any joint may be affected, with the development of osteoarthritis, arthralgia, and an increase in fracture risk.

The aims of the present project are to evaluate the dimensions of hands and feet with the 3D scanner method and to perform a quantitative analysis of movement through Gait Analysis technique in de novo patients with acromegaly (group # 1) and in patients with different disease status (group #2).

Eligibility criteria

Qualifiers

De novo patients with acromegaly (group # 1), diagnosed according to Endocrine Society guidelines,

Age equal to18 years or older

Acromegalic patients with different disease status (group #2)

Age equal to18 years or older

Disqualifiers

Cardiorespiratory, neurological or musculoskeletal disorder

Previous orthopaedic surgery

Previous lower limbs traumatic injuries

Trial design

Treatments tested in this trial

  • Medical surgery therapy

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Istituto Auxologico Italiano

Lead sponsor

Politecnico di Milano

Collaborator